Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Parietal pleura-based malignant perivascular epithelioid cell neoplasm protruding into serous cavity: A hitherto unrecognized occurrence.

Pelosi G, Sabella G, Cannone M, Balladore E, Papanikolaou N, Incarbone M, Zompatori M, Harari S, Bedini AV.

J Thorac Oncol. 2019 Dec 5. pii: S1556-0864(19)33713-X. doi: 10.1016/j.jtho.2019.11.021. [Epub ahead of print] No abstract available.

PMID:
31812753
2.

Novel evidence for a greater burden of ambient air pollution on cardiovascular disease.

Mannucci PM, Harari S, Franchini M.

Haematologica. 2019 Dec;104(12):2349-2357. doi: 10.3324/haematol.2019.225086. Epub 2019 Oct 31. Review.

3.

RISE-IIP: some pitfalls and observations.

Harari S.

Lancet Respir Med. 2019 Nov;7(11):e35. doi: 10.1016/S2213-2600(19)30378-9. No abstract available.

PMID:
31645285
4.

Pulmonary hypertension and chronic lung disease: where are we headed?

Elia D, Caminati A, Zompatori M, Cassandro R, Lonati C, Luisi F, Pelosi G, Provencher S, Harari S.

Eur Respir Rev. 2019 Oct 21;28(153). pii: 190065. doi: 10.1183/16000617.0065-2019. Print 2019 Sep 30. Review.

5.

Rare pulmonary disease and orphan drugs: a path to the future.

Harari S, Adir Y, Humbert M.

Eur Respir Rev. 2019 Oct 1;28(153). pii: 190115. doi: 10.1183/16000617.0115-2019. Print 2019 Sep 30. No abstract available.

6.

Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue.

Caminati A, Lonati C, Cassandro R, Elia D, Pelosi G, Torre O, Zompatori M, Uslenghi E, Harari S.

Eur Respir Rev. 2019 Oct 1;28(153). pii: 190044. doi: 10.1183/16000617.0044-2019. Print 2019 Sep 30. Review.

7.

Lung Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: A Series Contribution to a Debated Procedure.

Harari S, Cereda F, Pane F, Cavazza A, Papanikolaou N, Pelosi G, Scarioni M, Uslenghi E, Zompatori M, Caminati A.

Medicina (Kaunas). 2019 Sep 19;55(9). pii: E606. doi: 10.3390/medicina55090606.

8.

Spread of hyperplastic pulmonary neuroendocrine cells into air spaces (S.H.I.P.M.E.N.T.S): A proof for artifact.

Pelosi G, Nesa F, Taietti D, Servillo SP, Papanikolaou N, Zompatori M, Meroni A, Harari S, Incarbone M.

Lung Cancer. 2019 Nov;137:43-47. doi: 10.1016/j.lungcan.2019.09.006. Epub 2019 Sep 13.

PMID:
31542567
9.

Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.

Harari S, Davì M, Biffi A, Caminati A, Ghirardini A, Lovato V, Cricelli C, Lapi F.

Intern Emerg Med. 2019 Sep 20. doi: 10.1007/s11739-019-02195-0. [Epub ahead of print]

PMID:
31541394
10.

Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis.

Vancheri C, Sebastiani A, Tomassetti S, Pesci A, Rogliani P, Tavanti L, Luppi F, Harari S, Rottoli P, Ghirardini A, Kirchgaessler KU, Albera C.

Respir Med. 2019 Sep;156:78-84. doi: 10.1016/j.rmed.2019.08.006. Epub 2019 Aug 13.

PMID:
31445389
11.

Unusual presentation of acute pulmonary hypertension in a patient with bilateral pneumonia and hypertrophic cardiomyopathy.

Sonaglioni A, Lombardo M, Rigamonti E, Vincenti A, Nicolosi GL, Trevisan R, Zompatori M, Cassandro R, Harari S, Anzà C.

J Cardiovasc Med (Hagerstown). 2019 Dec;20(12):853-856. doi: 10.2459/JCM.0000000000000848. No abstract available.

PMID:
31389821
12.

Risk of breast cancer in patients with lymphangioleiomyomatosis.

Nuñez O, Baldi BG, Radzikowska E, Carvalho CRR, Herranz C, Sobiecka M, Torre O, Harari S, Vergeer MAMH, Kolbe J, Pollán M, Pujana MA.

Cancer Epidemiol. 2019 Aug;61:154-156. doi: 10.1016/j.canep.2019.06.004. Epub 2019 Jun 28.

PMID:
31260937
13.

Giant Secondary Overgrowth of Type-1 Pulmonary Cystic Airway Malformation Upon Development of Anaplastic Lymphoma Kinase-Rearranged Adenocarcinoma.

Pelosi G, Vandoni A, Meroni A, Uslenghi E, Callipo F, Papanikolaou N, Cannone M, Balladore E, D'Amico ME, Harari S, Zompatori M, Incarbone M.

J Thorac Oncol. 2019 Nov;14(11):2019-2022. doi: 10.1016/j.jtho.2019.06.004. Epub 2019 Jun 20. No abstract available.

PMID:
31228624
14.

Who's Afraid of the Big Bad Wolf? Safety of Beta-Blockers in COPD.

Ambrosio G, Harari S, Abraha I.

EClinicalMedicine. 2019 Jan 29;7:9-10. doi: 10.1016/j.eclinm.2019.01.007. eCollection 2019 Jan. No abstract available.

15.

Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept.

Pelosi G, Massa F, Gatti G, Righi L, Volante M, Birocco N, Maisonneuve P, Sonzogni A, Harari S, Albini A, Papotti M.

Clin Pathol. 2019 Feb 19;12:2632010X19829259. doi: 10.1177/2632010X19829259. eCollection 2019 Jan-Dec.

16.

Incremental prognostic value of global left atrial peak strain in women with new-onset gestational hypertension.

Sonaglioni A, Lonati C, Lombardo M, Rigamonti E, Binda G, Vincenti A, Nicolosi GL, Bianchi S, Harari S, Anzà C.

J Hypertens. 2019 Aug;37(8):1668-1675. doi: 10.1097/HJH.0000000000002086.

PMID:
30950977
17.

Recent advances in the molecular landscape of lung neuroendocrine tumors.

Pelosi G, Bianchi F, Hofman P, Pattini L, Ströbel P, Calabrese F, Naheed S, Holden C, Cave J, Bohnenberger H, Dinter H, Harari S, Albini A, Sonzogni A, Papotti M, Volante M, Ottensmeier CH.

Expert Rev Mol Diagn. 2019 Apr;19(4):281-297. doi: 10.1080/14737159.2019.1595593. Epub 2019 Mar 27.

PMID:
30900485
18.

Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids.

Proietti M, Agosti P, Lonati C, Corrao S, Perticone F, Mannucci PM, Nobili A, Harari S; REPOSI Investigators.

J Am Med Dir Assoc. 2019 Oct;20(10):1313-1317.e9. doi: 10.1016/j.jamda.2019.01.132. Epub 2019 Mar 7.

PMID:
30852169
19.

Fibrosing interstitial lung diseases: knowns and unknowns.

Cottin V, Wollin L, Fischer A, Quaresma M, Stowasser S, Harari S.

Eur Respir Rev. 2019 Feb 27;28(151). pii: 180100. doi: 10.1183/16000617.0100-2018. Print 2019 Mar 31. Review.

20.

Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography.

Shteyer E, Shekhtman L, Zinger T, Harari S, Gafanovich I, Wolf D, Ivgi H, Barsuk R, Dery I, Armoni D, Rivkin M, Pipalia R, Eliav MC, Skorochod Y, Breuer GS, Tur-Kaspa R, Wiener YW, Stern A, Cotler SJ, Dahari H, Lurie Y.

PLoS One. 2019 Feb 7;14(2):e0212252. doi: 10.1371/journal.pone.0212252. eCollection 2019.

21.

The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone.

Harari S, Caminati A, Confalonieri M, Poletti V, Vancheri C, Pesci A, Rogliani P, Luppi F, Agostini C, Rottoli P, Sanduzzi Zamparelli A, Sebastiani A, Della Porta R, Salton F, Messore B, Tomassetti S, Rosso R, Biffi A, Puxeddu E, Cerri S, Cinetto F, Refini RM, Bocchino M, Di Michele L, Specchia C, Albera C; ILDINET (Interstitial Lung Diseases Italian Network).

Clin Respir J. 2019 Mar;13(3):166-173. doi: 10.1111/crj.12999.

PMID:
30675755
22.

Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography.

Shteyer E, Shekhtman L, Zinger T, Harari S, Gafanovich I, Wolf D, Ivgi H, Barsuk R, Dery I, Armoni D, Rivkin M, Pipalia R, Cohen Eliav M, Skorochod Y, Breuer GS, Tur-Kaspa R, Weil Wiener Y, Stern A, Cotler SJ, Dahari H, Lurie Y.

PLoS One. 2019 Jan 15;14(1):e0210173. doi: 10.1371/journal.pone.0210173. eCollection 2019. Erratum in: PLoS One. 2019 Feb 7;14(2):e0212252.

23.

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease.

Harari S.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180110. doi: 10.1183/16000617.0110-2018. Print 2018 Dec 31. No abstract available.

24.

The changing face of the European Respiratory Review.

Harari S.

Eur Respir Rev. 2018 Dec 19;27(150). pii: 180102. doi: 10.1183/16000617.0102-2018. Print 2018 Dec 31. No abstract available.

25.

Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management.

van Cleemput J, Sonaglioni A, Wuyts WA, Bengus M, Stauffer JL, Harari S.

Adv Ther. 2019 Feb;36(2):298-317. doi: 10.1007/s12325-018-0857-z. Epub 2018 Dec 15. Review.

26.

Pulmonary hypertension in chronic lung disease and hypoxia.

Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J, Provencher S, Weissmann N, Seeger W.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801914. doi: 10.1183/13993003.01914-2018. Print 2019 Jan.

27.

Air travel and incidence of pneumothorax in lymphangioleiomyomatosis.

Gonano C, Pasquier J, Daccord C, Johnson SR, Harari S, Leclerc V, Falconer L, Miano E, Cordier JF, Cottin V, Lazor R.

Orphanet J Rare Dis. 2018 Dec 13;13(1):222. doi: 10.1186/s13023-018-0964-6.

28.

CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy.

Schlafstein AJ, Withers AE, Rudra S, Danelia D, Switchenko JM, Mister D, Harari S, Zhang H, Daddacha W, Ehdaivand S, Li X, Torres MA, Yu DS.

Int J Breast Cancer. 2018 Oct 14;2018:6945129. doi: 10.1155/2018/6945129. eCollection 2018.

29.

Randomised controlled trials and real-life studies: two answers for one question.

Harari S.

Eur Respir Rev. 2018 Sep 26;27(149). pii: 180080. doi: 10.1183/16000617.0080-2018. Print 2018 Sep 30. No abstract available.

30.

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal.

Pelosi G, Papotti M, Righi L, Rossi G, Ferrero S, Bosari S, Calabrese F, Kern I, Maisonneuve P, Sonzogni A, Albini A, Harari S, Barbieri F, Capelletto E, Catino AM, Cavone D, De Palma A, Fusco N, Lunardi F, Maiorano E, Marzullo A, Novello S, Papanikolaou N, Pasello G, Pennella A, Pezzuto F, Punzi A, Prisciandaro E, Rea F, Rosso L, Scattone A, Serio G.

J Thorac Oncol. 2018 Nov;13(11):1750-1761. doi: 10.1016/j.jtho.2018.07.002. Epub 2018 Jul 7.

31.

Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis.

Harari S, Spagnolo P, Cocconcelli E, Luisi F, Cottin V.

Curr Opin Pulm Med. 2018 Sep;24(5):469-476. doi: 10.1097/MCP.0000000000000502. Review.

PMID:
29927757
32.

Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.

Behr J, Nathan SD, Harari S, Wuyts W, Kirchgaessler KU, Bengus M, Gilberg F, Wells AU.

Respir Med. 2018 May;138:13-20. doi: 10.1016/j.rmed.2018.03.019. Epub 2018 Mar 16.

33.

Hemodynamic Mechanisms of Exercise-Induced Pulmonary Hypertension in Patients with Lymphangioleiomyomatosis: The Role of Exercise Stress Echocardiography.

Sonaglioni A, Baravelli M, Cassandro R, Torre O, Elia D, Anzà C, Harari S.

J Am Soc Echocardiogr. 2018 Aug;31(8):888-901. doi: 10.1016/j.echo.2018.02.004. Epub 2018 Mar 28.

PMID:
29605474
34.

A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis.

Harari S, Caminati A, Poletti V, Confalonieri M, Gasparini S, Lacedonia D, Luppi F, Pesci A, Sebastiani A, Spagnolo P, Vancheri C, Balestro E, Bonifazi M, Cerri S, De Giacomi F, Della Porta R, Foschino Barbaro MP, Fui A, Pasquinelli P, Rosso R, Tomassetti S, Specchia C, Rottoli P; for the ILDINET (Interstitial Lung Diseases Italian Network).

Respiration. 2018;95(6):433-440. doi: 10.1159/000487711. Epub 2018 Mar 27.

35.

Physiological insights of exercise hyperventilation in arterial and chronic thromboembolic pulmonary hypertension.

Farina S, Bruno N, Agalbato C, Contini M, Cassandro R, Elia D, Harari S, Agostoni P.

Int J Cardiol. 2018 May 15;259:178-182. doi: 10.1016/j.ijcard.2017.11.023.

PMID:
29579597
36.

Validation of multidisciplinary diagnosis in IPF.

Castillo D, Walsh S, Hansell DM, Vasakova M, Cottin V, Altinisik G, Palmucci S, Sterclova M, Harari S, Richeldi L, Vancheri C, Wells AU; ERICE ILD working group.

Lancet Respir Med. 2018 Feb;6(2):88-89. doi: 10.1016/S2213-2600(18)30023-7. Review. No abstract available.

PMID:
29413085
37.

The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.

Steagall WK, Pacheco-Rodriguez G, Darling TN, Torre O, Harari S, Moss J.

Am J Respir Cell Mol Biol. 2018 Jun;58(6):678-683. doi: 10.1165/rcmb.2017-0403TR. Review.

38.

Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm.

Pelosi G, Bianchi F, Dama E, Simbolo M, Mafficini A, Sonzogni A, Pilotto S, Harari S, Papotti M, Volante M, Fontanini G, Mastracci L, Albini A, Bria E, Calabrese F, Scarpa A.

Virchows Arch. 2018 Apr;472(4):567-577. doi: 10.1007/s00428-018-2307-3. Epub 2018 Feb 1.

39.

The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy.

Conti S, Harari S, Caminati A, Zanobetti A, Schwartz JD, Bertazzi PA, Cesana G, Madotto F.

Eur Respir J. 2018 Jan 25;51(1). pii: 1700397. doi: 10.1183/13993003.00397-2017. Print 2018 Jan.

40.

Severe idiopathic pulmonary fibrosis: A clinical approach.

Lipsi R, Mazzola D, Caminati A, Elia D, Lonati C, Harari S.

Eur J Intern Med. 2018 Apr;50:20-27. doi: 10.1016/j.ejim.2018.01.014. Epub 2018 Feb 1. Review.

PMID:
29361476
41.

Pulmonary hypertension: a paradigm for rare pulmonary diseases.

Harari S.

Eur Respir Rev. 2017 Dec 20;26(146). pii: 170120. doi: 10.1183/16000617.0120-2017. Print 2017 Dec 31. No abstract available.

42.

Recent advances in managing idiopathic pulmonary fibrosis.

Scelfo C, Caminati A, Harari S.

F1000Res. 2017 Nov 27;6:2052. doi: 10.12688/f1000research.10720.1. eCollection 2017. Review.

43.

Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis.

Montefusco L, Harari S, Elia D, Rossi A, Specchia C, Torre O, Adda G, Arosio M.

Eur J Intern Med. 2018 May;51:61-67. doi: 10.1016/j.ejim.2017.11.011. Epub 2017 Dec 1.

PMID:
29198444
44.

Classification of pulmonary neuroendocrine tumors: new insights.

Pelosi G, Sonzogni A, Harari S, Albini A, Bresaola E, Marchiò C, Massa F, Righi L, Gatti G, Papanikolaou N, Vijayvergia N, Calabrese F, Papotti M.

Transl Lung Cancer Res. 2017 Oct;6(5):513-529. doi: 10.21037/tlcr.2017.09.04. Review.

45.

New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.

Torre O, Elia D, Caminati A, Harari S.

Eur Respir Rev. 2017 Sep 27;26(145). pii: 170042. doi: 10.1183/16000617.0042-2017. Print 2017 Sep 30. Review.

46.

Severe idiopathic pulmonary fibrosis: what can be done?

Caminati A, Cassandro R, Torre O, Harari S.

Eur Respir Rev. 2017 Sep 27;26(145). pii: 170047. doi: 10.1183/16000617.0047-2017. Print 2017 Sep 30. Review.

47.

Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.

Caliò A, Eble JN, Hes O, Martignoni G, Harari SE, Williamson SR, Brunelli M, Osunkoya AO, Wang L, Comperat E, Lopez-Beltran A, Wang M, Zhang S, Curless KL, Post KM, Chang HY, Luchini C, Baldrige LA, MacLennan GT, Montironi R, Grignon DJ, Cheng L.

Oncotarget. 2016 Aug 8;8(33):54096-54105. doi: 10.18632/oncotarget.11117. eCollection 2017 Aug 15.

48.

Rare pulmonary diseases: a common fight.

Harari S, Humbert M.

Eur Respir Rev. 2017 Sep 6;26(145). pii: 170059. doi: 10.1183/16000617.0059-2017. Print 2017 Sep 30. No abstract available.

49.

Current understanding and management of pulmonary Langerhans cell histiocytosis.

Vassallo R, Harari S, Tazi A.

Thorax. 2017 Oct;72(10):937-945. doi: 10.1136/thoraxjnl-2017-210125. Epub 2017 Jul 8. Review.

PMID:
28689173
50.

Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens.

Harari SE, Sassoon DJ, Priemer DS, Jacob JM, Eble JN, Caliò A, Grignon DJ, Idrees M, Albany C, Masterson TA, Hanna NH, Foster RS, Ulbright TM, Einhorn LH, Cheng L.

Urol Oncol. 2017 Oct;35(10):605.e9-605.e16. doi: 10.1016/j.urolonc.2017.05.018. Epub 2017 Jun 21. Review.

PMID:
28647396

Supplemental Content

Loading ...
Support Center